UCB

Performance

About UCB

UCB is a global biopharmaceutical leader focused on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions. The company operates worldwide with a focus on research, development, and patient support in areas such as epilepsy, Parkinson’s-related disorders, and autoimmune diseases. Based in Belgium, UCB emphasizes innovative science and patient-centric programs through its UCBCares initiative and ongoing clinical studies and publications.